LATEST ALERTS
Regulation and legislation
Council passes medical cannabis bill…
25th January 2023 - Alerts | District of Columbia, North America, United States |
Governor urges legislature to legalise medical cannabis…
25th January 2023 - Alerts | Kansas, North America, United States |
FDA publishes guidance for cannabis and clinical research…
25th January 2023 - Alerts | North America, United States |
CBD and THC to banned on hempseed labels…
25th January 2023 - Alerts | Asia, South Korea |
Father’s frustration as legal hold-ups keep medical cannabis out of Georgia
24th January 2023 - News analysis |
Licensed medical cannabis patients in the US state of Georgia can legally possess oils with less than 5% THC, but they can’t legally buy it due to legislative delays and a series of legal appeals
Decision expected on limited early start to coffee shop experiment…
24th January 2023 - Alerts | Europe, Netherlands |
EU legal doubt as Belgium’s new e-liquid rules amount to a ban on CBD vapes
23rd January 2023 - News analysis |
Belgium has set new rules for nicotine-free e-liquids, effectively banning all e-liquids containing CBD – and thereby setting up a possible conflict with EU law
Working group gets first proposals on recreational cannabis…
23rd January 2023 - Alerts | Czech Republic, Europe |
Updated regulations for cannabis consumption areas…
20th January 2023 - Alerts | New Jersey, North America, United States |
Senate bill to add medical cannabis qualifying conditions goes to House…
20th January 2023 - Alerts | North America, South Dakota, United States |
Russia: CBD and cannabis regulation, January 2023
19th January 2023 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
Kansas slow to legalise medical cannabis ‘because legislators want to get it right’
18th January 2023 - News analysis |
Legislation to create a medical cannabis programme in the US state of Kansas appeared to be on the verge of success many times – but it died again as the 2022 session drew to a close
Legalising cannabis ‘will burden German health system,’ says Bavarian minister
17th January 2023 - News analysis |
Cannabis consumption is a growing problem in Bavaria and its planned legalisation in Germany would further burden the country’s health system, Bavarian health minister Klaus Holetschek says
Denmark: CBD and cannabis regulation, January 2023
17th January 2023 - Regulatory reports |
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
French court overturns government ban on hemp flowers, shops can sell again
16th January 2023 - News analysis |
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
Belgium: CBD and cannabis regulation, January 2023
16th January 2023 - Regulatory reports |
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Ministry lacks resources for cannabis bill…
16th January 2023 - Alerts | Central America, Costa Rica |
Investigation over FDA inaction over CBD and hemp…
13th January 2023 - Alerts | North America, United States |
Health minister claims cannabis bill is on the way…
13th January 2023 - Alerts | Europe, Luxembourg |
FDA expected to issue recommendation ‘soon’ on CBD regulation in the US
13th January 2023 - News analysis |
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
German ministry punished for delay over cannabis legislation by €1m funding cut
12th January 2023 - News analysis |
The German Ministry of Health’s budget has been slashed by €1m in a bid to put pressure on health minister Karl Lauterbach to present a draft law for the legalisation of cannabis
Much-needed research into SCRAs’ huge medical potential faces high barriers
12th January 2023 - Blogs |
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
Importing and exporting of hemp and CBD in the EU
11th January 2023 - Regulatory reports |
This report provides an overview of the applicable framework for the movement of hemp and CBD within the borders of the EU as well as the import and export to and from “third countries”
Google changes policy to allow advertising of certain CBD products…
9th January 2023 - Alerts | North America, United States |
Senate passes bill to legalise recreational cannabis…
9th January 2023 - Alerts | North America, United States, Virgin Islands |
FDA to make regulation recommendations for CBD…
9th January 2023 - Alerts | North America, United States |
Recreational sales began on 29th December…
9th January 2023 - Alerts | New York, North America, United States |
Japan cannabinoid conference-goers look forward to future with legal reforms
9th January 2023 - News analysis |
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
Monaco: CBD and cannabis regulation, January 2023
9th January 2023 - Regulatory reports |
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
Colombia ready to lead Latin America into a more cannabis-friendly future
5th January 2023 - News analysis |
CannIntelligence reviews developments in cannabis regulation in Latin America in 2022 and looks forward to likely further opening-up of the industry in many of the region’s nations in 2023
Australia: CBD and cannabis regulation, January 2023
4th January 2023 - Regulatory reports |
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Is 2023 the year for the great leap forward on cannabis regulation?
3rd January 2023 - News analysis |
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
An overview of intoxicating hemp-derived cannabinoids in Europe
2nd January 2023 - Regulatory reports |
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
US FDA again issues warning letters on CBD in ingestibles, this time with a twist
30th December 2022 - News analysis |
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill
30th December 2022 - News analysis |
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The question of semi-synthetics – HHC comes under scrutiny by EU authorities
29th December 2022 - News analysis |
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
Two US cannabis companies fight out contract dispute in California courts
23rd December 2022 - News analysis |
A 2021 acquisition deal between two cannabis companies over a lucrative shopfront in Orange County, California, has resulted in both companies filing legal claims against each other
